_id
691843d73c536f8df231771d
Ticker
XERS
Name
Xeris Pharmaceuticals Inc
Exchange
NASDAQ
Address
1375 West Fulton Street, Chicago, IL, United States, 60607
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.xerispharma.com
Description
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Last Close
7.01
Volume
1384531
Current Price
7.17
Change
2.2824536376604874
Last Updated
2025-12-05T14:03:09.778Z
Image
https://logo.clearbit.com/www.xerispharma.com
Ipo Date
2018-06-21T00:00:00.000Z
Market Cap
1115011200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.5
Target Price
11.5
Strong Buy
4
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
74380000
Cost Of Revenue
10996000
Gross Profit
63384000
Operating Expenses
56653000
Operating Income
6731000
Interest Expense
7268000
Pretax Income
621000
Net Income
621000
Eps
0.003496280911409157
Dividends Per Share
-
Shares Outstanding
165924289
Income Tax Expense
-
EBITDA
11078000
Operating Margin
9.049475665501479
Total Other Income Expense Net
-6110000
Cash
91598000
Short Term Investments
-
Receivables
53751000
Inventories
67462000
Total Current Assets
224017000
Property Plant Equipment
27209000
Total Assets
370191000
Payables
6527000
Short Term Debt
6194000
Long Term Debt
219469000
Total Liabilities
371052000
Equity
-861000
Depreciation
3049000
Change In Working Capital
6136000
Cash From Operations
18432000
Capital Expenditures
363000
Cash From Investing
-71000
Cash From Financing
13850000
Net Change In Cash
32211000
PE
-
PB
-1479.112765609756
ROE
-72.12543554006969
ROA
0.16775124192646498
FCF
18069000
Fcf Percent
0.24292820650712557
Piotroski FScore
3
Health Score
50
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
74380000
Quarters > 0 > income Statement > cost Of Revenue
10996000
Quarters > 0 > income Statement > gross Profit
63384000
Quarters > 0 > income Statement > operating Expenses
56653000
Quarters > 0 > income Statement > operating Income
6731000
Quarters > 0 > income Statement > interest Expense
7268000
Quarters > 0 > income Statement > pretax Income
621000
Quarters > 0 > income Statement > net Income
621000
Quarters > 0 > income Statement > eps
0.003496280911409157
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
177617307
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
11078000
Quarters > 0 > income Statement > operating Margin
9.049475665501479
Quarters > 0 > income Statement > total Other Income Expense Net
-6110000
Quarters > 0 > balance Sheet > cash
91598000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
53751000
Quarters > 0 > balance Sheet > inventories
67462000
Quarters > 0 > balance Sheet > total Current Assets
224017000
Quarters > 0 > balance Sheet > property Plant Equipment
27209000
Quarters > 0 > balance Sheet > total Assets
370191000
Quarters > 0 > balance Sheet > payables
6527000
Quarters > 0 > balance Sheet > short Term Debt
6194000
Quarters > 0 > balance Sheet > long Term Debt
219469000
Quarters > 0 > balance Sheet > total Liabilities
371052000
Quarters > 0 > balance Sheet > equity
-861000
Quarters > 0 > cash Flow > net Income
621000
Quarters > 0 > cash Flow > depreciation
3049000
Quarters > 0 > cash Flow > change In Working Capital
6136000
Quarters > 0 > cash Flow > cash From Operations
18432000
Quarters > 0 > cash Flow > capital Expenditures
363000
Quarters > 0 > cash Flow > cash From Investing
-71000
Quarters > 0 > cash Flow > cash From Financing
13850000
Quarters > 0 > cash Flow > net Change In Cash
32211000
Quarters > 0 > ratios > PE
0.003496280911409157
Quarters > 0 > ratios > PB
-1479.112765609756
Quarters > 0 > ratios > ROE
-72.12543554006969
Quarters > 0 > ratios > ROA
0.16775124192646498
Quarters > 0 > ratios > FCF
18069000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.24292820650712557
Quarters > 0 > health Score
50
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
71539000
Quarters > 1 > income Statement > cost Of Revenue
14609000
Quarters > 1 > income Statement > gross Profit
56930000
Quarters > 1 > income Statement > operating Expenses
52448000
Quarters > 1 > income Statement > operating Income
4482000
Quarters > 1 > income Statement > interest Expense
7358000
Quarters > 1 > income Statement > pretax Income
-1928000
Quarters > 1 > income Statement > net Income
-1928000
Quarters > 1 > income Statement > eps
-0.012361189230521612
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
155972048
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
8594000
Quarters > 1 > income Statement > operating Margin
6.265114133549532
Quarters > 1 > income Statement > total Other Income Expense Net
-6410000
Quarters > 1 > balance Sheet > cash
59285000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
53048000
Quarters > 1 > balance Sheet > inventories
67282000
Quarters > 1 > balance Sheet > total Current Assets
185578000
Quarters > 1 > balance Sheet > property Plant Equipment
27687000
Quarters > 1 > balance Sheet > total Assets
334686000
Quarters > 1 > balance Sheet > payables
9462000
Quarters > 1 > balance Sheet > short Term Debt
6156000
Quarters > 1 > balance Sheet > long Term Debt
218626000
Quarters > 1 > balance Sheet > total Liabilities
353990000
Quarters > 1 > balance Sheet > equity
-19304000
Quarters > 1 > cash Flow > net Income
-1928000
Quarters > 1 > cash Flow > depreciation
2918000
Quarters > 1 > cash Flow > change In Working Capital
-6882000
Quarters > 1 > cash Flow > cash From Operations
182000
Quarters > 1 > cash Flow > capital Expenditures
13000
Quarters > 1 > cash Flow > cash From Investing
-279000
Quarters > 1 > cash Flow > cash From Financing
942000
Quarters > 1 > cash Flow > net Change In Cash
845000
Quarters > 1 > ratios > PE
-0.012361189230521612
Quarters > 1 > ratios > PB
-57.93201326978865
Quarters > 1 > ratios > ROE
9.987567343555739
Quarters > 1 > ratios > ROA
-0.5760623390282235
Quarters > 1 > ratios > FCF
169000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.002362347810285299
Quarters > 1 > health Score
22
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
60119000
Quarters > 2 > income Statement > cost Of Revenue
8728000
Quarters > 2 > income Statement > gross Profit
51391000
Quarters > 2 > income Statement > operating Expenses
54481000
Quarters > 2 > income Statement > operating Income
-3090000
Quarters > 2 > income Statement > interest Expense
7305000
Quarters > 2 > income Statement > pretax Income
-9220000
Quarters > 2 > income Statement > net Income
-9220000
Quarters > 2 > income Statement > eps
-0.0604804582031
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
152445935
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
1228000
Quarters > 2 > income Statement > operating Margin
-5.139806051331526
Quarters > 2 > income Statement > total Other Income Expense Net
-6130000
Quarters > 2 > balance Sheet > cash
58440000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
46330000
Quarters > 2 > balance Sheet > inventories
52690000
Quarters > 2 > balance Sheet > total Current Assets
163494000
Quarters > 2 > balance Sheet > property Plant Equipment
27791000
Quarters > 2 > balance Sheet > total Assets
315453000
Quarters > 2 > balance Sheet > payables
6352000
Quarters > 2 > balance Sheet > short Term Debt
18076000
Quarters > 2 > balance Sheet > long Term Debt
217805000
Quarters > 2 > balance Sheet > total Liabilities
350581000
Quarters > 2 > balance Sheet > equity
-35128000
Quarters > 2 > cash Flow > net Income
-9220000
Quarters > 2 > cash Flow > depreciation
3143000
Quarters > 2 > cash Flow > change In Working Capital
-9241000
Quarters > 2 > cash Flow > cash From Operations
-10031000
Quarters > 2 > cash Flow > capital Expenditures
13000
Quarters > 2 > cash Flow > cash From Investing
-13000
Quarters > 2 > cash Flow > cash From Financing
-3137000
Quarters > 2 > cash Flow > net Change In Cash
-13181000
Quarters > 2 > ratios > PE
-0.0604804582031
Quarters > 2 > ratios > PB
-31.115843599123206
Quarters > 2 > ratios > ROE
26.246868594853108
Quarters > 2 > ratios > ROA
-2.922780889704647
Quarters > 2 > ratios > FCF
-10044000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.16706864718308687
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
60099000
Quarters > 3 > income Statement > cost Of Revenue
9478000
Quarters > 3 > income Statement > gross Profit
50621000
Quarters > 3 > income Statement > operating Expenses
48942000
Quarters > 3 > income Statement > operating Income
1679000
Quarters > 3 > income Statement > interest Expense
7703000
Quarters > 3 > income Statement > pretax Income
-5113000
Quarters > 3 > income Statement > net Income
-5113000
Quarters > 3 > income Statement > eps
-0.034294058614374755
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
149092881
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
5723000
Quarters > 3 > income Statement > operating Margin
2.793723689246077
Quarters > 3 > income Statement > total Other Income Expense Net
-6792000
Quarters > 3 > balance Sheet > cash
71621000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
40415000
Quarters > 3 > balance Sheet > inventories
48175000
Quarters > 3 > balance Sheet > total Current Assets
167662000
Quarters > 3 > balance Sheet > property Plant Equipment
28211000
Quarters > 3 > balance Sheet > total Assets
323060000
Quarters > 3 > balance Sheet > payables
2290000
Quarters > 3 > balance Sheet > short Term Debt
21182000
Quarters > 3 > balance Sheet > long Term Debt
217006000
Quarters > 3 > balance Sheet > total Liabilities
352675000
Quarters > 3 > balance Sheet > equity
-29615000
Quarters > 3 > cash Flow > net Income
-5113000
Quarters > 3 > cash Flow > depreciation
3133000
Quarters > 3 > cash Flow > change In Working Capital
-474000
Quarters > 3 > cash Flow > cash From Operations
1975000
Quarters > 3 > cash Flow > capital Expenditures
220000
Quarters > 3 > cash Flow > cash From Investing
10016000
Quarters > 3 > cash Flow > cash From Financing
398000
Quarters > 3 > cash Flow > net Change In Cash
12389000
Quarters > 3 > ratios > PE
-0.034294058614374755
Quarters > 3 > ratios > PB
-36.09643615633969
Quarters > 3 > ratios > ROE
17.264899544149927
Quarters > 3 > ratios > ROA
-1.5826781402835388
Quarters > 3 > ratios > FCF
1755000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.029201817001946788
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
203070000
Annuals > 0 > income Statement > cost Of Revenue
36832000
Annuals > 0 > income Statement > gross Profit
166238000
Annuals > 0 > income Statement > operating Expenses
199884000
Annuals > 0 > income Statement > operating Income
-33646000
Annuals > 0 > income Statement > interest Expense
33175000
Annuals > 0 > income Statement > pretax Income
-57104000
Annuals > 0 > income Statement > net Income
-54836000
Annuals > 0 > income Statement > eps
-0.3736109502428921
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
146773000
Annuals > 0 > income Statement > income Tax Expense
-2268000
Annuals > 0 > income Statement > EBITDA
-13994000
Annuals > 0 > income Statement > operating Margin
-16.568670901659527
Annuals > 0 > income Statement > total Other Income Expense Net
-23458000
Annuals > 0 > balance Sheet > cash
71621000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
40415000
Annuals > 0 > balance Sheet > inventories
48175000
Annuals > 0 > balance Sheet > total Current Assets
167662000
Annuals > 0 > balance Sheet > property Plant Equipment
28211000
Annuals > 0 > balance Sheet > total Assets
323060000
Annuals > 0 > balance Sheet > payables
2290000
Annuals > 0 > balance Sheet > short Term Debt
21182000
Annuals > 0 > balance Sheet > long Term Debt
217006000
Annuals > 0 > balance Sheet > total Liabilities
352675000
Annuals > 0 > balance Sheet > equity
-29615000
Annuals > 0 > cash Flow > net Income
-54836000
Annuals > 0 > cash Flow > depreciation
12625000
Annuals > 0 > cash Flow > change In Working Capital
-8820000
Annuals > 0 > cash Flow > cash From Operations
-36981000
Annuals > 0 > cash Flow > capital Expenditures
868000
Annuals > 0 > cash Flow > cash From Investing
4883000
Annuals > 0 > cash Flow > cash From Financing
36168000
Annuals > 0 > cash Flow > net Change In Cash
4070000
Annuals > 0 > ratios > PE
-0.3736109502428921
Annuals > 0 > ratios > PB
-33.304560526760085
Annuals > 0 > ratios > ROE
185.1629241938207
Annuals > 0 > ratios > ROA
-16.97393673001919
Annuals > 0 > ratios > FCF
-37849000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.18638400551533954
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
163914000
Annuals > 1 > income Statement > cost Of Revenue
28645000
Annuals > 1 > income Statement > gross Profit
135269000
Annuals > 1 > income Statement > operating Expenses
179279000
Annuals > 1 > income Statement > operating Income
-44010000
Annuals > 1 > income Statement > interest Expense
26609000
Annuals > 1 > income Statement > pretax Income
-63504000
Annuals > 1 > income Statement > net Income
-62255000
Annuals > 1 > income Statement > eps
-0.45218859388392174
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
137674857
Annuals > 1 > income Statement > income Tax Expense
-1249000
Annuals > 1 > income Statement > EBITDA
-23735000
Annuals > 1 > income Statement > operating Margin
-26.84944544090194
Annuals > 1 > income Statement > total Other Income Expense Net
-19494000
Annuals > 1 > balance Sheet > cash
67449000
Annuals > 1 > balance Sheet > short Term Investments
5002000
Annuals > 1 > balance Sheet > receivables
39197000
Annuals > 1 > balance Sheet > inventories
38838000
Annuals > 1 > balance Sheet > total Current Assets
156264000
Annuals > 1 > balance Sheet > property Plant Equipment
29175000
Annuals > 1 > balance Sheet > total Assets
322602000
Annuals > 1 > balance Sheet > payables
11565000
Annuals > 1 > balance Sheet > short Term Debt
3495000
Annuals > 1 > balance Sheet > long Term Debt
190932000
Annuals > 1 > balance Sheet > total Liabilities
329384000
Annuals > 1 > balance Sheet > equity
-6782000
Annuals > 1 > cash Flow > net Income
-62255000
Annuals > 1 > cash Flow > depreciation
13160000
Annuals > 1 > cash Flow > change In Working Capital
-6294000
Annuals > 1 > cash Flow > cash From Operations
-47023000
Annuals > 1 > cash Flow > capital Expenditures
2263000
Annuals > 1 > cash Flow > cash From Investing
-6004000
Annuals > 1 > cash Flow > cash From Financing
-1613000
Annuals > 1 > cash Flow > net Change In Cash
-54640000
Annuals > 1 > ratios > PE
-0.45218859388392174
Annuals > 1 > ratios > PB
-136.41625465054557
Annuals > 1 > ratios > ROE
917.9445591271012
Annuals > 1 > ratios > ROA
-19.29777248746133
Annuals > 1 > ratios > FCF
-49286000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.30068206498529715
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
110248000
Annuals > 2 > income Statement > cost Of Revenue
22634000
Annuals > 2 > income Statement > gross Profit
87614000
Annuals > 2 > income Statement > operating Expenses
169554000
Annuals > 2 > income Statement > operating Income
-81940000
Annuals > 2 > income Statement > interest Expense
14102000
Annuals > 2 > income Statement > pretax Income
-96084000
Annuals > 2 > income Statement > net Income
-94660000
Annuals > 2 > income Statement > eps
-0.6979347685509768
Annuals > 2 > income Statement > dividends Per Share
147050000
Annuals > 2 > income Statement > shares Outstanding
135628721
Annuals > 2 > income Statement > income Tax Expense
-1424000
Annuals > 2 > income Statement > EBITDA
-69314000
Annuals > 2 > income Statement > operating Margin
-74.3233437341267
Annuals > 2 > income Statement > total Other Income Expense Net
-14144000
Annuals > 2 > balance Sheet > cash
121966000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
30830000
Annuals > 2 > balance Sheet > inventories
24735000
Annuals > 2 > balance Sheet > total Current Assets
186818000
Annuals > 2 > balance Sheet > property Plant Equipment
9508000
Annuals > 2 > balance Sheet > total Assets
344522000
Annuals > 2 > balance Sheet > payables
4606000
Annuals > 2 > balance Sheet > short Term Debt
1580000
Annuals > 2 > balance Sheet > long Term Debt
187075000
Annuals > 2 > balance Sheet > total Liabilities
299335000
Annuals > 2 > balance Sheet > equity
45187000
Annuals > 2 > cash Flow > net Income
-94660000
Annuals > 2 > cash Flow > depreciation
12668000
Annuals > 2 > cash Flow > change In Working Capital
-35150000
Annuals > 2 > cash Flow > cash From Operations
-102891000
Annuals > 2 > cash Flow > capital Expenditures
524000
Annuals > 2 > cash Flow > cash From Investing
34461000
Annuals > 2 > cash Flow > cash From Financing
127473000
Annuals > 2 > cash Flow > net Change In Cash
59043000
Annuals > 2 > ratios > PE
-0.6979347685509768
Annuals > 2 > ratios > PB
20.17007115143736
Annuals > 2 > ratios > ROE
-209.48502887998762
Annuals > 2 > ratios > ROA
-27.475749008771572
Annuals > 2 > ratios > FCF
-103415000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.9380215514113635
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
49590000
Annuals > 3 > income Statement > cost Of Revenue
13318000
Annuals > 3 > income Statement > gross Profit
36272000
Annuals > 3 > income Statement > operating Expenses
151428000
Annuals > 3 > income Statement > operating Income
-115156000
Annuals > 3 > income Statement > interest Expense
7180000
Annuals > 3 > income Statement > pretax Income
-122725000
Annuals > 3 > income Statement > net Income
-122725000
Annuals > 3 > income Statement > eps
-1.5529490391531955
Annuals > 3 > income Statement > dividends Per Share
25089000
Annuals > 3 > income Statement > shares Outstanding
79027062
Annuals > 3 > income Statement > income Tax Expense
-110000
Annuals > 3 > income Statement > EBITDA
-113666000
Annuals > 3 > income Statement > operating Margin
-232.21617261544668
Annuals > 3 > income Statement > total Other Income Expense Net
-7569000
Annuals > 3 > balance Sheet > cash
67271000
Annuals > 3 > balance Sheet > short Term Investments
35162000
Annuals > 3 > balance Sheet > receivables
17456000
Annuals > 3 > balance Sheet > inventories
18118000
Annuals > 3 > balance Sheet > total Current Assets
142596000
Annuals > 3 > balance Sheet > property Plant Equipment
6627000
Annuals > 3 > balance Sheet > total Assets
304361000
Annuals > 3 > balance Sheet > payables
8924000
Annuals > 3 > balance Sheet > short Term Debt
1580000
Annuals > 3 > balance Sheet > long Term Debt
88067000
Annuals > 3 > balance Sheet > total Liabilities
209130000
Annuals > 3 > balance Sheet > equity
95231000
Annuals > 3 > cash Flow > net Income
-122725000
Annuals > 3 > cash Flow > depreciation
1879000
Annuals > 3 > cash Flow > change In Working Capital
11854000
Annuals > 3 > cash Flow > cash From Operations
-95535000
Annuals > 3 > cash Flow > capital Expenditures
1085000
Annuals > 3 > cash Flow > cash From Investing
97964000
Annuals > 3 > cash Flow > cash From Financing
27247000
Annuals > 3 > cash Flow > net Change In Cash
29673000
Annuals > 3 > ratios > PE
-1.5529490391531955
Annuals > 3 > ratios > PB
5.576564948808686
Annuals > 3 > ratios > ROE
-128.87085087839043
Annuals > 3 > ratios > ROA
-40.32218319692733
Annuals > 3 > ratios > FCF
-96620000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.948376688848558
Annuals > 3 > health Score
16
Valuation > metrics > PE
0.003496280911409157
Valuation > metrics > PB
-1479.112765609756
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-72.12543554006969
Profitability > metrics > ROA
0.2772111045143895
Profitability > metrics > Net Margin
0.008349018553374563
Profitability > final Score
2
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
0.9261144744083655
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
17.61001493593271
Liquidity > metrics > Quick Ratio
12.30681550192595
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
20
Prev Profitabilities > 1
40
Prev Profitabilities > 2
35
Prev Risks > 0
32
Prev Risks > 1
28
Prev Risks > 2
31
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:26:47.935Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0035
Earnings History > 0 > eps Estimate
0.0067
Earnings History > 0 > eps Difference
-0.0032
Earnings History > 0 > surprise Percent
-47.7612
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
-0.03
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
66.6667
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.06
Earnings History > 2 > eps Estimate
-0.04
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-50
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-04
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.03
Earnings History > 3 > eps Estimate
-0.02
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-50
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-08
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.11
Earnings History > 4 > eps Estimate
-0.09
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-22.2222
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.1
Earnings History > 5 > eps Estimate
-0.11
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
9.0909
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.14
Earnings History > 6 > eps Estimate
-0.12
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-16.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-06
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1
Earnings History > 7 > eps Estimate
-0.1
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.09
Earnings History > 8 > eps Estimate
-0.12
Earnings History > 8 > eps Difference
0.03
Earnings History > 8 > surprise Percent
25
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-08
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.14
Earnings History > 9 > eps Estimate
-0.13
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-7.6923
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.12
Earnings History > 10 > eps Estimate
-0.17
Earnings History > 10 > eps Difference
0.05
Earnings History > 10 > surprise Percent
29.4118
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-08
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.1
Earnings History > 11 > eps Estimate
-0.16
Earnings History > 11 > eps Difference
0.06
Earnings History > 11 > surprise Percent
37.5
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.16
Earnings History > 12 > eps Estimate
-0.16
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-10
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.19
Earnings History > 13 > eps Estimate
-0.23
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
17.3913
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.25
Earnings History > 14 > eps Estimate
-0.25
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.42
Earnings History > 15 > eps Estimate
-0.24
Earnings History > 15 > eps Difference
-0.18
Earnings History > 15 > surprise Percent
-75
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.39
Earnings History > 16 > eps Estimate
-0.37
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-5.4054
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.41
Earnings History > 17 > eps Estimate
-0.3
Earnings History > 17 > eps Difference
-0.11
Earnings History > 17 > surprise Percent
-36.6667
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.3
Earnings History > 18 > eps Estimate
-0.34
Earnings History > 18 > eps Difference
0.04
Earnings History > 18 > surprise Percent
11.7647
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-09
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.41
Earnings History > 19 > eps Estimate
-0.38
Earnings History > 19 > eps Difference
-0.03
Earnings History > 19 > surprise Percent
-7.8947
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.35
Earnings History > 20 > eps Estimate
-0.52
Earnings History > 20 > eps Difference
0.17
Earnings History > 20 > surprise Percent
32.6923
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.63
Earnings History > 21 > eps Estimate
-0.73
Earnings History > 21 > eps Difference
0.1
Earnings History > 21 > surprise Percent
13.6986
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.89
Earnings History > 22 > eps Estimate
-0.89
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-11
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.23
Earnings History > 23 > eps Estimate
-1.13
Earnings History > 23 > eps Difference
-0.1
Earnings History > 23 > surprise Percent
-8.8496
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-07
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.22
Earnings History > 24 > eps Estimate
-1.23
Earnings History > 24 > eps Difference
0.01
Earnings History > 24 > surprise Percent
0.813
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-06
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.28
Earnings History > 25 > eps Estimate
-0.94
Earnings History > 25 > eps Difference
-0.34
Earnings History > 25 > surprise Percent
-36.1702
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-09
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.07
Earnings History > 26 > eps Estimate
-0.76
Earnings History > 26 > eps Difference
-0.31
Earnings History > 26 > surprise Percent
-40.7895
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-06
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.98
Earnings History > 27 > eps Estimate
-0.93
Earnings History > 27 > eps Difference
-0.05
Earnings History > 27 > surprise Percent
-5.3763
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-07
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.71
Earnings History > 28 > eps Estimate
-0.78
Earnings History > 28 > eps Difference
0.07
Earnings History > 28 > surprise Percent
8.9744
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-13
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-3.07
Earnings History > 29 > eps Estimate
-0.88
Earnings History > 29 > eps Difference
-2.19
Earnings History > 29 > surprise Percent
-248.8636
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-06-21
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-4.69
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-4.69
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-02-03
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-1.29
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-1.29
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-12-31
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-4.43
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-4.43
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-09-30
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-3.7182
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-3.7182
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-04
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.23
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.23
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-31
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-2.2946
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-2.2946
Earnings History > 35 > surprise Percent
-
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWalleye Capital LLC Sells 448,444 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
12/11/2025
Walleye Capital LLC Sells 448,444 Shares of Xeris Biopharma Holdings, Inc. $XERS MarketBeat
Read more →Jump Financial LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
12/11/2025
Jump Financial LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. $XERS MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$11.5
Analyst Picks
Strong Buy
4
Buy
1
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 14.16% of the total shares of Xeris Pharmaceuticals Inc
1.
Vanguard Total Stock Mkt Idx Inv(2.9699%)
since
2025/07/31
2.
iShares Russell 2000 ETF(2.2569%)
since
2025/08/31
3.
Vanguard Institutional Extnd Mkt Idx Tr(1.0693%)
since
2025/07/31
4.
Fidelity Small Cap Index(0.9279%)
since
2025/06/30
5.
Nuveen Quant Small Cap Equity R6(0.8515%)
since
2025/07/31
6.
iShares Russell 2000 Growth ETF(0.8238%)
since
2025/08/31
7.
CREF Stock R3(0.54%)
since
2025/07/31
8.
Fidelity Extended Market Index(0.5372%)
since
2025/07/31
9.
Heptagon Driehaus US Micro Cap Eq C$ Acc(0.5353%)
since
2025/07/31
10.
Vanguard Russell 2000 ETF(0.443%)
since
2025/07/31
11.
SPDR® S&P Pharmaceuticals ETF(0.4146%)
since
2025/08/31
12.
Xtrackers S&P 500 Swap ETF 1C(0.3971%)
since
2025/07/31
13.
Kennedy Micro Cap(0.3701%)
since
2025/06/30
14.
State St Russell Sm Cap® Indx SL Cl I(0.3143%)
since
2025/08/31
15.
Vanguard Health Care ETF(0.2801%)
since
2025/07/31
16.
Nuveen Quant Small/Mid Cap Eq R6(0.2577%)
since
2025/07/31
17.
Wellington Management Company LLP(0.2473%)
since
2025/06/30
18.
Vanguard US Momentum Factor ETF(0.2381%)
since
2025/06/30
19.
Schwab Small Cap Index(0.2376%)
since
2025/07/31
20.
NT R2000 Index Fund - NL(0.2247%)
since
2025/06/30
21.
Calamos Timpani Small Cap Growth I(0.2225%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0035
EPS Estimate
0.0067
EPS Difference
-0.0032
Surprise Percent
-47.7612%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.